Evidence map›Paper›PMID 41909343›Full record

ArticleCureus2026

Where Is the Lactate Coming From? An Unusual Presentation of Persistent Lactic Acidosis.

Waleed Sadiq, Madeeha Subhan Waleed

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Waleed SadiqPulmonary and Critical Care Medicine, Robert Wood Johnson (RWJ) Barnabas Health, New Jersey, USA.
Madeeha Subhan WaleedInternal Medicine, Lower Bucks Hospital, Bristol, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Persistent lactic acidosis in patients with metastatic colorectal cancer is uncommon and often attributed to impaired hepatic clearance from liver metastases. Acute worsening, however, may signal reversible metabolic derangements, including medication-related toxicity. A 64-year-old male with type 2 diabetes mellitus, hypertension, and metastatic colorectal cancer to the liver presented with weakness, lethargy, and inability to tolerate oral intake for three days. His baseline lactate was persistently elevated (5-7 mmol/L) over six months. On presentation, he was hypotensive [blood pressure (BP) 82/41 mmHg], tachycardic [heart rate (HR) 122 bpm], febrile (101°F), and drowsy. Labs showed acute kidney injury (AKI) (Cr 2.7 mg/dL), hyperkalemia [Potassium (K) 6.1 mmol/L], severe metabolic acidosis (bicarbonate 4 mmol/L), transaminitis [aspartate aminotransferase (AST) 424, alanine transaminase (ALT) 576], and lactate 18 mmol/L. Complete blood count showed a white blood cell (WBC) count of 19,000/µL. Computed tomography (CT) of the abdomen revealed the known 7 cm colorectal mass with multiple hepatic metastases, moderate ascites, and no obstruction or ischemia. Despite aggressive intravenous (IV) fluids and vasopressors, lactate rose to 20 mmol/L, and urine output remained negligible. Medication review revealed metformin use, raising suspicion for metformin-associated lactic acidosis (MALA) in the setting of AKI. Nephrology consultation was obtained, and continuous renal replacement therapy (CRRT) was initiated. Lactate declined to 12 mmol/L at four hours and 6 mmol/L at 12 hours. Hemodynamics improved, vasopressors were discontinued, urine output increased, and creatinine and bicarbonate normalized on day two. Eventually, the patient was successfully extubated, tolerated oral intake, and was discharged home after completing antibiotics. This case illustrates multifactorial lactic acidosis: baseline elevation from liver metastases, superimposed type A lactic acidosis from sepsis, and type B lactic acidosis from metformin accumulation. Early recognition and initiation of CRRT were critical for rapid lactate clearance and clinical recovery. In patients with baseline lactic acidosis due to metastatic liver disease, sudden lactate spikes should prompt evaluation for reversible causes, including renal dysfunction and medication toxicity. Multidisciplinary management and renal support can be lifesaving.

Indexed as

acidosis lacticcolorectal cancercritical care: metforminmetformin induced lactic acidosis

Identifiers

PMID41909343
PMCPMC13032916

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.